These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9099233)

  • 21. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain.
    Thomson CJ; Amyes SG
    FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallo-β-lactamases: structural features, antibiotic recognition, inhibition, and inhibitor design.
    Wang JF; Chou KC
    Curr Top Med Chem; 2013; 13(10):1242-53. PubMed ID: 23647546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to clavulanic acid.
    Saves I; Burlet-Schiltz O; Swarén P; Lefèvre F; Masson JM; Promé JC; Samama JP
    J Biol Chem; 1995 Aug; 270(31):18240-5. PubMed ID: 7629142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological, and chiroptical activity of 3-phenyl-clavams.
    Cierpucha M; Solecka J; Frelek J; Szczukiewicz P; Chmielewski M
    Bioorg Med Chem; 2004 Jan; 12(2):405-16. PubMed ID: 14723959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.
    Frase H; Toth M; Champion MM; Antunes NT; Vakulenko SB
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1556-62. PubMed ID: 21220532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemistry and biosynthesis of clavulanic acid and other clavams.
    Baggaley KH; Brown AG; Schofield CJ
    Nat Prod Rep; 1997 Aug; 14(4):309-33. PubMed ID: 9281835
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemistry and action of clavulanic acid.
    Cole M
    Scott Med J; 1982; 27 Spec No.():S10-6. PubMed ID: 6762660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem.
    Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
    Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    J Antimicrob Chemother; 1992 Jul; 30(1):17-25. PubMed ID: 1331018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
    Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
    J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.